The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKier Regulatory News (KIE)

Share Price Information for Kier (KIE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 136.80
Bid: 115.00
Ask: 148.80
Change: 0.00 (0.00%)
Spread: 33.80 (29.391%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 136.80
KIE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

INFRASTRUCTURE AND REGIONAL BUILDING UPDATE

22 Jan 2018 07:00

RNS Number : 4619C
Kier Group PLC
22 January 2018
 

 

 

22 January 2018

 

KIER GROUP PLC

INFRASTRUCTURE AND REGIONAL BUILDING UPDATE

 

Kier, a leading property, residential, construction and services group, provides the following updates relating to its infrastructure and regional building businesses.

 

· HS2 and Highways England smart motorway joint ventures transfer from Carillion;

· £140m additional infrastructure contracts awarded; and

· £160m Public Health England contract award.

 

Infrastructure

Further to the announcement of 15 January and after discussions with the Government and their clients, Kier confirms the following:

· On HS2, Kier and Eiffage are now 50/50 joint venture partners delivering two of the seven civil engineering packages, lots C2 and C3. All 51 Carillion employees, including apprentices, working on the CEK HS2 joint venture have been offered the opportunity to join Kier/Eiffage with continuous service to the client being maintained; and

· Kier has assumed full responsibility for the Highways England smart motorway schemes on which it had been working in joint venture with Carillion. All employees currently working on the schemes have been offered the opportunity to join Kier. In total c.150 employees will be making the transition to Kier in the next week including seven apprentices. Engagement with the existing supply chain on this project has also taken place, again ensuring continuity of skills, resources and suppliers.

 

The above contracts are all performing well, operationally and financially.

 

In addition, following the acquisition of McNicholas in July 2017, a number of contract extensions have been awarded to this business, totalling £140m. These include:

· A five-year £31m 'Gas to the West' network distribution operation for SGN Natural Gas in Northern Ireland, which secures the Group's place as the principal contractor to three gas distributors in Northern Ireland;

· A £40m contract extension to 2022 to the Phoenix Natural Gas contract in Northern Ireland, and;

· A one-year £30m contract extension to 2020 for the Network Rail CP5 High Voltage and Electrification and Plant framework.

 

Regional Building

In regional building, the Group has been awarded a £160m Public Health England contract for a new 17,000m² bioscience facility in Harlow, Essex. This is the largest lot of four in a new Public Health England development which will create a leading science campus and headquarters. The new building comprises specialist bioscience laboratories, an energy centre and associated support facilities. Work on the development is scheduled to commence in February 2018.

 

Haydn Mursell, chief executive of Kier, said: "We have been working collaboratively with our clients and are pleased to have reached agreement with Government concerning these joint ventures. We have been able to take action quickly and reassure the project teams that they continue to play an important role in the delivery of these contracts. The McNicholas acquisition is performing well, providing a highly complementary addition to our utilities services business, and the Public Health England award reflects our growing presence in the bioscience market."

 

The Group will announce its trading update for the half year ended 31 December 2017 on 25 January 2018.

 

- E N D S -

For further information, please contact:

 

Louise Turner-Smith, Kier Investor Relations

+44 (0) 07976 790012

Kier press office

+44 (0)1767 355903

Richard Mountain / Nick Hasell, FTI Consulting

+44 (0) 20 3727 1340

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
UPDDMGZMLMDGRZM
Date   Source Headline
3rd May 202412:03 pmRNSDirector/PDMR Shareholding
1st May 202411:17 amRNSTotal Voting Rights
17th Apr 202412:30 pmRNSDirector/PDMR Shareholding
8th Apr 202411:26 amRNSDirector/PDMR Shareholding
5th Apr 202410:15 amRNSDirector/PDMR Shareholding
2nd Apr 20243:19 pmRNSDirector/PDMR Shareholding
2nd Apr 20241:00 pmRNSTotal Voting Rights
20th Mar 20245:48 pmRNSDirector/PDMR Shareholding
19th Mar 202410:12 amRNSDirector/PDMR Shareholding
15th Mar 20248:40 amRNSPost Stabilisation Notice
11th Mar 202410:37 amRNSBlock Listing Application
7th Mar 20247:00 amRNSResults for the period ended 31 December 2023
1st Mar 202410:11 amRNSTotal Voting Rights
1st Mar 20247:00 amRNSGreen Economy Mark and SBTi certifications
20th Feb 20241:43 pmRNSDirector/PDMR Shareholding
15th Feb 202411:05 amRNSKier Group plc successfully issues Senior Notes
15th Feb 202410:09 amRNSHolding(s) in Company
8th Feb 20245:22 pmRNSKier Group plc Announces Pricing of Senior Notes
6th Feb 202410:59 amRNSPre Stabilisation Notice
5th Feb 20248:03 amRNSKier Announces Proposed Offer of Senior Notes
1st Feb 20242:16 pmRNSTotal Voting Rights
22nd Jan 202410:30 amRNSDirector/PDMR Shareholding
18th Jan 20247:00 amRNSTrading Update
5th Jan 202411:47 amRNSHolding(s) in Company
2nd Jan 20243:44 pmRNSBlock listing Interim Review
2nd Jan 20243:42 pmRNSTotal Voting Rights
27th Dec 202310:10 amRNSReduction of Capital
27th Dec 202310:05 amRNSHolding(s) in Company
27th Dec 202310:02 amRNSHolding(s) in Company
21st Dec 202312:21 pmRNSDirector/PDMR Shareholding
19th Dec 20233:57 pmRNSDirector/PDMR Shareholding
18th Dec 20234:50 pmRNSDirector/PDMR Shareholding
14th Dec 202310:35 amRNSDirectorate Change
1st Dec 202310:53 amRNSTotal Voting Rights
22nd Nov 202311:09 amRNSDirector/PDMR Shareholding
20th Nov 20233:10 pmRNSDirector/PDMR Shareholding
16th Nov 20234:00 pmRNSResult of AGM
16th Nov 20237:00 amRNSAGM Trading Update
1st Nov 202312:28 pmRNSTotal Voting Rights
1st Nov 202312:24 pmRNSDirector/PDMR Shareholding
30th Oct 20234:00 pmRNSDirector/PDMR Shareholding
24th Oct 20239:37 amRNSHolding(s) in Company
20th Oct 202312:00 pmRNSDirector/PDMR Shareholding
10th Oct 202310:09 amRNSHolding(s) in Company
6th Oct 20232:34 pmRNSAnnual Financial Report
2nd Oct 202311:15 amRNSTotal Voting Rights
22nd Sep 20232:00 pmRNSDirector/PDMR Shareholding
22nd Sep 202310:09 amRNSHolding(s) in Company
20th Sep 20231:42 pmRNSHolding(s) in Company
20th Sep 20231:39 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.